KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Gross Profit (2016 - 2025)

Historic Gross Profit for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $5.9 billion.

  • Medtronic's Gross Profit rose 811.8% to $5.9 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $22.8 billion, marking a year-over-year increase of 608.95%. This contributed to the annual value of $21.9 billion for FY2025, which is 357.95% up from last year.
  • Latest data reveals that Medtronic reported Gross Profit of $5.9 billion as of Q4 2025, which was up 811.8% from $5.6 billion recorded in Q3 2025.
  • Medtronic's 5-year Gross Profit high stood at $5.9 billion for Q4 2025, and its period low was $4.9 billion during Q3 2022.
  • Over the past 5 years, Medtronic's median Gross Profit value was $5.4 billion (recorded in 2021), while the average stood at $5.4 billion.
  • In the last 5 years, Medtronic's Gross Profit skyrocketed by 4823.25% in 2021 and then plummeted by 990.91% in 2022.
  • Quarter analysis of 5 years shows Medtronic's Gross Profit stood at $5.4 billion in 2021, then dropped by 5.61% to $5.1 billion in 2022, then rose by 3.43% to $5.2 billion in 2023, then grew by 4.48% to $5.5 billion in 2024, then grew by 8.12% to $5.9 billion in 2025.
  • Its Gross Profit was $5.9 billion in Q4 2025, compared to $5.6 billion in Q3 2025 and $5.8 billion in Q2 2025.